Skip to main content
Erschienen in: Pediatric Cardiology 1/2019

08.10.2018 | Original Article

Short-Term and Mid-Term Results of Minimally Invasive Occlusion of Ventricular Septal Defects via a Subaxillary Approach in a Single Center

verfasst von: Xiaosong Hu, Bangtian Peng, Yanwei Zhang, Feng Ai, Jiayong Zheng

Erschienen in: Pediatric Cardiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

This retrospective, single-center study evaluated short-term and mid-term results of minimally invasive surgery to occlude ventricular septal defects (VSDs) using a subaxillary approach. The procedure was performed on 429 children (224 boys, 205 girls; age 2.4 ± 2.5 years; mean weight 12.7 ± 10.1 kg) between January 2014 and December 2016 at the Children’s Heart Center of Henan Province People’s Hospital. An approximately 2-cm subaxillary incision was made between the third and fifth ribs, and the appropriate right atrium or ventricle was punctured under the guidance of transencephalographic echocardiography (TEE). The VSD was then occluded under TEE guidance. The mean size of the VSDs was 4.2 ± 1.0 mm, and the occluder measured 5.3 ± 1.3 mm. Asymmetrical occluders were used in 44 patients and symmetrical occluders in 385 patients. The operative time was 60.7 ± 21.3 min, and time in the intensive care unit was 20.9 ± 6.5 h. Blood loss was 12.4 ± 14.4 ml. There were no deaths among these patients. Occluder displacement occurred in two cases. There were no complications (e.g., third-degree atrioventricular block, new aortic regurgitation, reoperation for massive bleeding, serious infection). All patients were followed for 6–48 months, during which time there were ten cases of a postoperative residual shunt, which self-closed in eight during follow-up. The other two cases are still being followed. No complications occurred during follow-up (e.g., reoperation, aortic regurgitation, atrioventricular block, occluder abscission). Occluding VSDs using the subaxillary approach is safe and effective. Short-term and mid-term results are satisfactory. Further follow-up is required regarding long-term results.
Literatur
3.
Zurück zum Zitat Xing Q, Pan S, An Q et al (2010) Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: multicenter experience and mid-term follow-up. J Thorac Cardiovasc Surg 139(6):1409–1415CrossRefPubMed Xing Q, Pan S, An Q et al (2010) Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: multicenter experience and mid-term follow-up. J Thorac Cardiovasc Surg 139(6):1409–1415CrossRefPubMed
4.
Zurück zum Zitat Hongxin L, Zhang N, Wenbin G et al (2014) Peratrial device closure of perimembranous ventricular septal defects through a right parasternal approach. Ann Thorac Surg 98(2):668–674CrossRefPubMed Hongxin L, Zhang N, Wenbin G et al (2014) Peratrial device closure of perimembranous ventricular septal defects through a right parasternal approach. Ann Thorac Surg 98(2):668–674CrossRefPubMed
5.
Zurück zum Zitat Hazekamp MG et al (2010) Surgery for transposition of the great arteries, ventricular septal defect and lef ventricular outfowtractobstruction: European Congenital Heart Surgeons Association multicentre study. Eur J Cardiothorac Surg 38:699–706CrossRefPubMed Hazekamp MG et al (2010) Surgery for transposition of the great arteries, ventricular septal defect and lef ventricular outfowtractobstruction: European Congenital Heart Surgeons Association multicentre study. Eur J Cardiothorac Surg 38:699–706CrossRefPubMed
6.
Zurück zum Zitat Tao K, Zhu D, An Q et al (2012) Perventricular device closure of patent ductus arteriosus: a secondary chance. Ann Thorac Surg 93:1007–1009CrossRefPubMed Tao K, Zhu D, An Q et al (2012) Perventricular device closure of patent ductus arteriosus: a secondary chance. Ann Thorac Surg 93:1007–1009CrossRefPubMed
7.
Zurück zum Zitat Zhang GC, Chen Q, Cao H et al (2013) Minimally invasive perventricular device closure of ventricular septal defect in infants under transthoracicechocardiograhic guidance: feasibility and comparison with transesophageal echocardiography. Cardiovasc Ultrasound 11:8CrossRefPubMedPubMedCentral Zhang GC, Chen Q, Cao H et al (2013) Minimally invasive perventricular device closure of ventricular septal defect in infants under transthoracicechocardiograhic guidance: feasibility and comparison with transesophageal echocardiography. Cardiovasc Ultrasound 11:8CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hu S, Yang Y, Wu Q et al (2014) Results of two different approaches to closure of subaortic ventricular septal defects in children. Eur J Cardiothorac Surg 46:648–653CrossRefPubMed Hu S, Yang Y, Wu Q et al (2014) Results of two different approaches to closure of subaortic ventricular septal defects in children. Eur J Cardiothorac Surg 46:648–653CrossRefPubMed
9.
Zurück zum Zitat Yin S, Zhu D, Lin K et al (2014) Perventricular device closure of congenital ventricular septal defects. J Card Surg 29:390–400CrossRefPubMed Yin S, Zhu D, Lin K et al (2014) Perventricular device closure of congenital ventricular septal defects. J Card Surg 29:390–400CrossRefPubMed
10.
Zurück zum Zitat Ou-Yang WB, Li SJ, Wang SZ et al (2015) Echocardiographic guided closure of perimembranous ventricular septal defects. Ann Thorac Surg 100:1398–1402CrossRefPubMed Ou-Yang WB, Li SJ, Wang SZ et al (2015) Echocardiographic guided closure of perimembranous ventricular septal defects. Ann Thorac Surg 100:1398–1402CrossRefPubMed
11.
Zurück zum Zitat Xing Q, Wu Q, Shi L et al (2015) Minimally invasive transthoracic device closure of isolated ventricular septal defects without cardiopulmonary bypass: long-term follow-up results. J Thorac Cardiovasc Surg 149:257–264CrossRefPubMed Xing Q, Wu Q, Shi L et al (2015) Minimally invasive transthoracic device closure of isolated ventricular septal defects without cardiopulmonary bypass: long-term follow-up results. J Thorac Cardiovasc Surg 149:257–264CrossRefPubMed
12.
Zurück zum Zitat Sun JJ, Fan TB, Peng BT et al (2015) Effect of surgical treatment of congenital heart disease by right subaxillary small incision surgery. Chin J Pract Med 42(5):20–21 Sun JJ, Fan TB, Peng BT et al (2015) Effect of surgical treatment of congenital heart disease by right subaxillary small incision surgery. Chin J Pract Med 42(5):20–21
13.
Zurück zum Zitat Song SB, Fan T, Li B et al (2016) Minimally invasive closure via subaxillary approach for common congenital heart disease: a mid-term follow-up study. Chin J Thorac Cardiovasc Surg 32(11):680–682 Song SB, Fan T, Li B et al (2016) Minimally invasive closure via subaxillary approach for common congenital heart disease: a mid-term follow-up study. Chin J Thorac Cardiovasc Surg 32(11):680–682
14.
Zurück zum Zitat Liang WJ, Fan TB, Li B et al (2015) Surgical closure of perimembranous ventricular septal defect through small incision via right subaxillary approach. Chin J Chin J Appl Clin Pediatr 30(13):1037–1038 Liang WJ, Fan TB, Li B et al (2015) Surgical closure of perimembranous ventricular septal defect through small incision via right subaxillary approach. Chin J Chin J Appl Clin Pediatr 30(13):1037–1038
15.
Zurück zum Zitat Wang S, Zhuang Z, Zhang H et al (2014) Perventricular closure of perimembranous ventricular septal defects using the concentric occluder device. Pediatr Cardiol 35(4):580–586CrossRefPubMed Wang S, Zhuang Z, Zhang H et al (2014) Perventricular closure of perimembranous ventricular septal defects using the concentric occluder device. Pediatr Cardiol 35(4):580–586CrossRefPubMed
16.
Zurück zum Zitat Luo YK, Chen WH, Xiong C et al (2015) Comparison of effectiveness and cost between perventricular device occlusion and minimally invasive surgical repair for perimembranous ventricular septal defect. Pediatr Cardiol 36(2):308–313CrossRefPubMed Luo YK, Chen WH, Xiong C et al (2015) Comparison of effectiveness and cost between perventricular device occlusion and minimally invasive surgical repair for perimembranous ventricular septal defect. Pediatr Cardiol 36(2):308–313CrossRefPubMed
17.
Zurück zum Zitat Zhou SJ, Fan TB, Song SB et al (2017) Follow-up results of minimally invasive closure of subarterial ventricular septal defect through left subaxillary approach. Chin J Appl Clin Pediatr 32(13):993–995 Zhou SJ, Fan TB, Song SB et al (2017) Follow-up results of minimally invasive closure of subarterial ventricular septal defect through left subaxillary approach. Chin J Appl Clin Pediatr 32(13):993–995
18.
Zurück zum Zitat Hu SS, Pan XB, Chang Q (2017) Expert consensus on interventional diagnosis and treatment of common cardiovascular diseases through surgical approaches. Chin Circ J 32(2):105–119 Hu SS, Pan XB, Chang Q (2017) Expert consensus on interventional diagnosis and treatment of common cardiovascular diseases through surgical approaches. Chin Circ J 32(2):105–119
Metadaten
Titel
Short-Term and Mid-Term Results of Minimally Invasive Occlusion of Ventricular Septal Defects via a Subaxillary Approach in a Single Center
verfasst von
Xiaosong Hu
Bangtian Peng
Yanwei Zhang
Feng Ai
Jiayong Zheng
Publikationsdatum
08.10.2018
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 1/2019
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-018-1980-y

Weitere Artikel der Ausgabe 1/2019

Pediatric Cardiology 1/2019 Zur Ausgabe

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

LDL-Cholesterin kann ApoB als Risikomarker nicht ersetzen

16.05.2024 Hypercholesterinämie Nachrichten

Apolipoprotein B (ApoB) ist ein genauer Risikomarker für atherosklerotisch bedingte Erkrankungen. Aber das LDL-Cholesterin doch auch – lohnt sich also die ApoB-Messung überhaupt?

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.